Dominik Andrzej Ślazyk

Dominik Andrzej Ślazyk

Auto-generated profile, based on publicly available information

Dominik Andrzej Ślazyk

The University Hospital in Krakow, Krakow, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2026 in Quality in Sport
Verified
Journal Article
Open access
MSMarzena Swojnóg
Marzena Swojnóg
MBMagdalena Barczewska
Magdalena Barczewska
DBDominika Bieszczad
Dominika Bieszczad
BRBarbara Reizer
Barbara Reizer
ZBZofia Botto
Zofia Botto
KKKlaudia Krystek
Klaudia Krystek
Background. Metabolic Syndrome (MetS) is a prevalent cluster of conditions that significantly increases the risk of cardiovascular disease and type 2 diabetes mellitus. Lifestyle modification is universally recognized as the primary therapeutic strategy, with aerobic exercise playing a crucial role in improving metabolic health and reducing mortality risks in affected populations. Aim. This review synthesizes current evidence on the efficacy and mechanisms of aerobic exercise as a fundamental non-pharmacological strategy for managing Metabolic Syndrome (MetS). Material and methods. A search of major databases (2015–2025) was performed, focusing on systematic reviews and RCTs. Keywords included "Metabolic Syndrome," "aerobic exercise," "insulin resistance," "dyslipidemia," and "exercise prescription." Results. Regular aerobic exercise improves cardiometabolic risk factors independently of significant weight loss. It enhances insulin sensitivity via GLUT4 translocation, optimizes the lipid profile (reducing triglycerides, increasing HDL), and reduces visceral adiposity and inflammation. Additionally, High-Intensity Interval Training (HIIT) is highlighted as a potent strategy, often offering superior efficacy to moderate-intensity continuous training (MICT). Conclusions. Aerobic exercise is an essential component of MetS management. Professionals should prioritize individualized prescriptions, incorporating both MICT and HIIT, to effectively mitigate cardiometabolic risk and improve patient health.

15 February 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
BRBarbara Reizer
Barbara Reizer
ZBZofia Botto
Zofia Botto
KKKlaudia Krystek
Klaudia Krystek
PFPatrycja Felisiak
Patrycja Felisiak
DKDominika Kowalczyk
Dominika Kowalczyk
DŚDominik Andrzej Ślazyk
Dominik Andrzej Ślazyk
Introduction: Semaglutide (Ozempic) is a long-acting GLP-1 receptor agonist used in the treatment of type 2 diabetes and obesity. Its potent effects on appetite suppression, delayed gastric emptying, and weight reduction are well documented. Increasing scientific attention has focused on its potential influence on lean body mass and skeletal muscle, as emerging evidence suggests that semaglutide-induced weight loss may include clinically relevant reductions in muscle mass. Understanding the extent and significance of these changes is essential for safe long-term therapy. Material and Methods of Research: A literature review was conducted using PubMed, Google Scholar, and Scopus. Clinical trials, observational studies, meta-analyses, and relevant preclinical research published in English between 2018 and 2024 were analyzed. Results:Evidence indicates that semaglutide-induced weight loss consistently leads to reductions in lean mass, typically comprising 20–40% of total weight lost. Mechanisms include caloric deficit, reduced protein intake, appetite suppression, and changes in anabolic signalin. Several studies demonstrated preserved muscle strength or stabilization of lean mass when therapy was combined with adequate protein intake and resistance training. Preclinical findings suggest that part of the lean mass reduction is reversible after treatment discontinuation. Conclusion: Semaglutide affects muscle mass primarily indirectly through appetite suppression and significant weight reduction. While lean mass loss is common, functional muscle decline is not inevitable and may be mitigated through dietary optimization and structured physical activity. Regular monitoring of body composition should be considered during semaglutide therapy.

31 January 2026 in Quality in Sport
Verified
Journal Article
Open access
ZŚZofia Śliwa
Zofia Śliwa
ZBZofia Botto
Zofia Botto
KKKlaudia Krystek
Klaudia Krystek
PFPatrycja Felisiak
Patrycja Felisiak
BRBarbara Reizer
Barbara Reizer
DŚDominik Andrzej Ślazyk
Dominik Andrzej Ślazyk
Pilates is widely implemented in sport, rehabilitation, and health-oriented exercise programs, with well-documented benefits for strength, flexibility, balance, and functional performance. However, its effectiveness in inducing skeletal muscle hypertrophy remains uncertain. This narrative review summarizes and critically evaluates the current state of knowledge regarding the effects of mat-based and reformer-based Pilates on muscle mass–related outcomes. Evidence from randomized controlled trials, comparative studies, and systematic reviews examining lean body mass, fat-free mass, appendicular lean mass, or muscle size was synthesized. Available findings indicate that clinically meaningful increases in muscle mass following Pilates training are inconsistent across populations and study designs. Mat Pilates generally demonstrates minimal effects on lean mass, while reformer Pilates is mechanistically better positioned to promote hypertrophy due to its capacity for external loading and progression; nevertheless, empirical support for this effect remains limited and heterogeneous. Overall, Pilates reliably improves strength and functional outcomes but does not consistently elicit robust muscle mass gains. Reformer Pilates may offer advantages over mat Pilates for muscle mass accretion when progressive resistance is emphasized, although further high-quality, hypertrophy-focused trials are required to clarify its role.

24 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PFPatrycja Felisiak
Patrycja Felisiak
MBMagdalena Barszczewska
Magdalena Barszczewska
DBDominika Bieszczad
Dominika Bieszczad
ZBZofia Botto
Zofia Botto
DKDominika Kowalczyk
Dominika Kowalczyk
ZŚZofia Śliwa
Zofia Śliwa
Children and adolescents, as the new generation of avid technology users, are often able to use it to their great benefit. However, it comes with the cost of being exposed to a variety of health risks, cognitive health being one of the main areas affected. As developing brains are the most susceptible to these risks, Manfred Spitzer’s concept of digital dementia seems as relevant as ever nowadays. In the present study, we analyse over a hundred published works with the goal of creating a compact yet comprehensive summary of existing knowledge on digital dementia in the population of infants, preschoolers, schoolchildren and adolescents. Findings suggest that multiple cognition areas are affected, with memory, critical thinking and problem solving being among the most alarming. While the role of parents as guardians of digital health cannot be overstated, other factors such as environment and unmodifiable traits also play a role. For preventing and mitigating this problem, a collaborative effort of caretakers but also teachers, doctors and policy makers is most urgently needed. We conclude that digital dementia among youth is a common problem, therefore recognising symptoms early, minimising risks and preventing its progression will prove beneficial to whole generations.

23 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
BRBarbara Reizer
Barbara Reizer
ZBZofia Botto
Zofia Botto
MSMarzena Swojnóg
Marzena Swojnóg
KKKlaudia Krystek
Klaudia Krystek
PFPatrycja Felisiak
Patrycja Felisiak
DŚDominik Andrzej Ślazyk
Dominik Andrzej Ślazyk
Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. One of its rare but clinically significant complications is the shrinking lung syndrome (SLS), which affects less than 1% of patients and presents diagnostic and therapeutic challenges. Aim: This paper aims to present a comprehensive overview of shrinking lung syndrome as a rare manifestation of SLE, with a focus on its pathophysiology, diagnostic difficulties, and current therapeutic approaches. Materials and Methods: A narrative review was conducted based on selected scientific publications indexed in PubMed, Scopus, and Google Scholar. The inclusion criteria included articles describing the pathophysiology, clinical features, diagnosis, and treatment of SLS in the context of SLE. Results: SLS is characterized by progressive dyspnea, diaphragmatic elevation, and restrictive defects on pulmonary function testing. The exact pathogenesis remains unclear but involves neuromuscular dysfunction, diaphragmatic weakness, pleural involvement, and potential autoantibody-mediated mechanisms. Diagnosis is challenging due to the absence of specific markers and requires exclusion of other causes. Treatment primarily includes corticosteroids and immunosuppressants, with adjunctive respiratory rehabilitation. Despite therapy, pulmonary restriction may persist. Conclusions: SLS remains an under-recognized and underdiagnosed complication of SLE. Increased clinical awareness and early diagnostic interventions are key to preventing long-term respiratory impairment. Future research is needed to establish standardized diagnostic protocols and treatment guidelines.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ZBZofia Botto
Zofia Botto
BRBarbara Reizer
Barbara Reizer
MSMarzena Swojnóg
Marzena Swojnóg
KKKlaudia Krystek
Klaudia Krystek
PFPatrycja Felisiak
Patrycja Felisiak
DŚDominik Andrzej Ślazyk
Dominik Andrzej Ślazyk
The rapid digitalization of health care, propelled by the COVID-19 pandemic, has led to a rapidly growing gap in use of medical technology for senior patients. The inclusion of wearable medical devices, patient portals, telemedicine, and access to information has created an opportunity for patients to have more control over their health than ever before. However, for elderly patients it also comes with new challenges due to fear or reluctance to use advanced technologies they are not familiar with, leaving them to rely on family members and caregivers. It was found that health care provider’s hesitation in offering digital options and the expenses associated with digital devices are another obstacle. There is a significant need for modification in health care personnel attitudes regarding technology, promotion of combining community centers and health care for improving overall quality of life and digital literacy, and advocacy for senior patients' opinions when creating new medical technology and possibly incorporating AI technology to aid in bridging the gap.